Format

Send to

Choose Destination
See comment in PubMed Commons below
Semergen. 2014 Jul-Aug;40(5):241-6. doi: 10.1016/j.semerg.2013.09.013. Epub 2014 Feb 12.

[A 6-year evaluation of dyslipidemia in a health center: Importance of improvement actions].

[Article in Spanish]

Author information

1
Centro de Salud Fuensanta, Valencia, España. Electronic address: fanton250v@gmail.com.
2
Centro de Salud Fuensanta, Valencia, España.

Abstract

INTRODUCTION:

Dyslipidemia, especially an increased LDL-cholesterol, has been shown to be one of the most important risk factors in the genesis of coronary involvement. The prevalence of dyslipidemias in Spain is high. The objective of this study is to assess the progress of dyslipidemic patients in our health center over a 6-year period, and see if there has been any improvement in its control after the presentation of the evaluation of the first 3 years, as well as an updated dyslipidemia protocol.

PATIENTS AND METHODS:

Assessment Period 1 (2006-2008): 267 patients with dyslipidemia. Assessment Period 2 (2009-2011): 222 patients, excluding exitus and address changes.

VARIABLES:

age, sex, personal history of CVD, vascular risk factors, lipids, drug treatment, risk levels, and percentages of CV control objectives.

RESULTS:

Mean age was 66.2 years (SD 13.4), 66.3% women. Period 1-Period 2: Total cholesterol: 221.9-196.6 mg/dl (P=.000); LDL-cholesterol: 147.9-115.8 mg/dl (P=.000). In high risk patients, therapeutic targets: 14-50.5% (P=.024); medium risk: 35-68.1% (P=.038); low risk: 44-68.2% (P=NS). Pharmacotherapy 68-77% (P=.000). Changing treatment: 30-43% (P=.001). Adherence: 75-86% (P=.003). Untreated high risk: 15.4-16.3% (P=NS).

CONCLUSIONS:

There was a significant improvement in Period 2, especially in high-risk patients, after presenting the results of the evaluation for Period 1 and with the updated dyslipidemia protocol. There are high risk patients without lipid-lowering treatment to be detected and reviewed.

KEYWORDS:

Assessment; Atención Primaria; Dislipidemia; Dyslipidemia; Evaluación; Primary Care

PMID:
24529919
DOI:
10.1016/j.semerg.2013.09.013
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center